27 Apr 2020The project Catechol-Based Membranes for Tissue Regeneration (TIRECAT) has been selected for its participation in the 6th edition of the Preacceleration Program promoted by Barcelona Activa and co-finaced by ERDF. TIRECAT is a biotech project and is coordinated by Dr. Daniel Ruiz-Molina, as the scientific leader of the project, Dr. Salvio Suárez-García as a scientific entrepreneur and with the support of Dr. Claudia Nieva from the Business and Innovation department in ICN2. It aims to validate a new technology based on catechol biomaterials for their application in tissue engineering and regenerative medicine. This program offers everything necessary for projects with a high technological impact to enter the market with guarantees of success. The participation of the TIRECAT project in the Barcelona Activa Preacceleration Program will allow the project to be advanced to stages closer to the clinic, define its business model, as well as explore its access to the market.